Skip to main content
Clinical Trials/ISRCTN75888393
ISRCTN75888393
Completed
未知

Feasibility and Acceptability of a New Clinical Pathway for the Identification of Non-responders to Glaucoma Eye Drops: The TRIAGE Study

Cardiff University0 sites53 target enrollmentMarch 5, 2019

Overview

Phase
未知
Intervention
Not specified
Conditions
Glaucoma / ocular hypertension
Sponsor
Cardiff University
Enrollment
53
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

2020 results in https://pubmed.ncbi.nlm.nih.gov/32139500/ (added 26/10/2020)

Registry
who.int
Start Date
March 5, 2019
End Date
July 31, 2019
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • RQ1: CLINICAL OBSERVATIONS, SITUATED INTERVIEWS AND SURVEY
  • Observations and Situated Interviews:
  • 1\. Aged 18 years or over
  • 2\. Attending an outpatient glaucoma clinic
  • 3\. Diagnosed with either glaucoma, ocular hypertension, normal tension glaucoma or pseudo\-exfoliative glaucoma
  • 4\. Cognitively able to participate in the study
  • 5\. Able to speak English or have access to an interpreter.
  • 6\. Healthcare professionals will be eligible for inclusion if they are providing care to patients fitting the inclusion criteria within either of the primary research sites.
  • 1\. Glaucoma specialist lead or nominated individual in a Welsh health board aside from Cwm Taf University Health Board and Cardiff and Vale University Health Board.
  • RQ2: SOP DEVELOPMENT AND FOCUS GROUPS ON STANDARD OPERATING PROCEDURE

Exclusion Criteria

  • RQ3: COHORT FEASIBILITY STUDY
  • CMGC Cohort Feasibility Study:
  • 1\. Ocular surgery in the last three months
  • 2\. Having a form of acute glaucoma
  • 3\. Already being prescribed and taking eye drops
  • 4\. Any other condition that may affect drop efficacy

Outcomes

Primary Outcomes

Not specified

Similar Trials